These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5312264)

  • 1. Studies on the non-neutralizable fraction of vaccinia virus.
    Majer M; Link F
    Clin Exp Immunol; 1970 Aug; 7(2):283-91. PubMed ID: 5312264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of neutralization of vaccinia virus by antiglobulin].
    Weeke-Lüttmann M
    Arch Gesamte Virusforsch; 1970; 31(1):28-32. PubMed ID: 5312165
    [No Abstract]   [Full Text] [Related]  

  • 3. Virus aggregation as the cause of the non-neutralizable persistent fraction.
    Wallis C; Melnick JL
    J Virol; 1967 Jun; 1(3):478-88. PubMed ID: 4318956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of rheumatoid factor with infectious vaccinia virus-antibody complexes.
    Gipson TG; Daniels CA; Notkins AL
    J Immunol; 1974 Jun; 112(6):2087-93. PubMed ID: 4207730
    [No Abstract]   [Full Text] [Related]  

  • 5. The antigenicity and immunogenicity of the intracellular and extracellular forms of vaccinia virus. I: The production of high-titre vaccinia extracellular virus and its antigenicity after inactivation.
    Thornton B
    Br J Exp Pathol; 1980 Aug; 61(4):444-50. PubMed ID: 7426394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disc plate assay of vaccinia antibodies.
    Minamitani M
    Arch Gesamte Virusforsch; 1968; 23(3):194-201. PubMed ID: 4176042
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of staphylococcal protein A with virus-IgG complexes.
    Austin RM; Daniels CA
    J Immunol; 1974 Nov; 113(5):1568-74. PubMed ID: 4371490
    [No Abstract]   [Full Text] [Related]  

  • 8. The neutralization of pox viruses. I. Evidence for antibody interference.
    M Neill TA
    J Hyg (Lond); 1968 Dec; 66(4):541-8. PubMed ID: 5250178
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
    Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
    J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversed passive haemagglutination-inhibition method for the estimation of antivaccinia antibodies.
    Nyerges G
    Immunology; 1969 Sep; 17(3):333-7. PubMed ID: 5352004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the vaccinia virus plaque neutralization test.
    O'Brien TC; Myers MG; Tauraso NM
    Appl Microbiol; 1971 May; 21(5):968-70. PubMed ID: 4995735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neutralization of vaccinia virus by antibodies to host antigens located on their surface].
    Rybakova AM; Kosiakov PN; Posevaia TA
    Vopr Virusol; 1969; 14(5):570-4. PubMed ID: 5316769
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a cofactor on the sensitivity of the vaccinia virus neutralization reaction in tissue culture].
    Piskareva NA; Gaeva LL
    Lab Delo; 1971; 12():733-6. PubMed ID: 4111447
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of the kinetics of neutralization of the vaccina virus by means of titration of the homologous antiserum.
    Rapicetta M; Mancini G; Santoro R
    Boll Ist Sieroter Milan; 1973; 52(4):315-20. PubMed ID: 4798236
    [No Abstract]   [Full Text] [Related]  

  • 15. [Irreversible inactivation of vaccinia and poliomyelitis viruses with homologous antibodies in the presence of cofactor].
    Shuratov IKh; Iabrov AA; Smorodintsev AA
    Vopr Virusol; 1968; 13(3):354-9. PubMed ID: 4302363
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation & characterization of immunogenic soluble antigens from vaccinia virus infected tissues.
    Singh LM; Pal SC
    Indian J Exp Biol; 1972 Mar; 10(2):94-100. PubMed ID: 4644881
    [No Abstract]   [Full Text] [Related]  

  • 17. The kinetics of the in vitro trimming of haemagglutinins from the particles of vaccinia and Ranikhet disease viruses by the lysates of the cells of virus infected CAM cultures.
    Babbar OP; Chowdhury BL
    Indian J Med Res; 1974 Nov; 62(11):1612-8. PubMed ID: 4475663
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on different strains of vaccinia virus with particular reference to their quality regarding immunogenicity and reactogenicity. 3. Studies in rabbits and monkeys (Macaca mulatta).
    Sehgal CL; Suri NK; Choudhury S; Murty DK; Raghavan NG
    Indian J Med Res; 1973 Sep; 61(9):1265-74. PubMed ID: 4205143
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
    He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
    J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity, pathogenicity, and transmissibility of a recombinant vaccinia virus in calves.
    Wedman EE; Smith AW; Oliver RE
    Am J Vet Res; 1988 Dec; 49(12):2018-21. PubMed ID: 3239835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.